EHR Alert for Tobacco Use Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new electronic health record (EHR) alert system to assist doctors in prescribing nicotine replacement therapy (NRT) for patients who smoke. The goal is to determine if this alert increases NRT prescriptions both in the hospital and after discharge. The trial involves two groups of doctors: one with the alert and one without. Potential participants are patients admitted to a general medicine service in Charleston and identified as smokers during nursing screenings. As an unphased trial, this study provides patients the opportunity to contribute to innovative research that could enhance smoking cessation support in healthcare settings.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this EHR alert is safe for use in hospitals?
Research has shown that nicotine replacement therapy (NRT) is generally safe for helping people quit smoking. It has been widely studied and used to treat tobacco dependence. In these studies, most participants found NRT easy to use without major issues.
Some mild side effects, such as skin irritation from patches or slight nausea from gum or lozenges, have been reported. However, these effects are usually not serious.
Importantly, long-term use of NRT has also been shown to be safe. It can help reduce smoking and increase the chances of quitting for good. For those considering joining a trial involving NRT, existing evidence suggests it is a safe option to consider.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it introduces a unique approach to treating Tobacco Use Disorder by integrating an Electronic Health Record (EHR) alert system. Unlike traditional methods that rely heavily on healthcare providers manually assessing and prescribing Nicotine Replacement Therapy (NRT), this system automatically inserts smoking history into patient records and prompts NRT prescribing during hospital stays. Additionally, it offers a direct referral for outpatient follow-up, streamlining the treatment process. This innovative use of technology aims to enhance the consistency and efficiency of care, potentially leading to better patient outcomes in quitting smoking.
What evidence suggests that this EHR alert is effective for increasing NRT prescribing?
Research has shown that nicotine replacement therapy (NRT) can increase the chances of quitting smoking by 50 to 70%. Without assistance, only 1 or 2 out of 10 people might succeed in quitting. However, with NRT, 5 to 7 people could succeed. One study found that combining NRT with support like counseling enables about 15% of people to quit smoking over six months. This evidence suggests that NRT is a helpful tool for quitting smoking. In this trial, participants in the experimental arm will receive an EHR alert prompting NRT prescribing, while the control group will receive routine care without the EHR alert.23678
Who Is on the Research Team?
Ellen Esposito, MD
Principal Investigator
Medical University of South Carolina
Are You a Good Fit for This Trial?
This trial is for hospitalized patients with nicotine addiction or tobacco use disorder. It's focused on whether an electronic health record (EHR) alert can help doctors remember to prescribe nicotine replacement therapy (NRT) during the hospital stay and at discharge.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of a non-interruptive EHR alert to increase NRT prescribing in hospitalized patients
Follow-up
Participants are monitored for changes in prescribing behaviors and smoking cessation outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Nicotine Replacement Therapy Prescribing
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
South Carolina Clinical & Translational Research Institute (SCTR)
Collaborator